Dark Canyon Laboratories to present at 2016 AGA Tech Summit

Dr. Bachwich will be presenting details about Dark Canyon Labs' new colonoscopy prep, DCL-101,  at the "Shark Tank" Session of the 2016 AGA Tech Summit in Boston, MA on Thursday, March 31, 2016. This conference on GI Innovation and Technology identifies unmet needs in gastroenterology and highlights promising new technologies.  A distinguished panel of moderators will provide valuable feedback.  

Dark Canyon Labs supports Colorectal Cancer Awareness Month in March

Colon cancer kills 50,000 patients every year and is the third leading cause of cancer in men and women in the U.S.  Many of these deaths can be prevented with regular screening.  Dark Canyon Laboratories is committed to providing patients with a much better experience during the colonoscopy prep process.  A better tolerated prep could help save lives by increasing the colon cancer screening rate. If patients don't dread the process, they will be more likely to comply with the current screening recommendations.

Learn more about colorectal cancer from the American College of Gastroenterology and from the American Cancer Society.

Dark Canyon Laboratories Plans Phase 2 Clinical Trial

Robarts Clinical Trials, Inc. has been retained by Dark Canyon Labs to conduct a Phase 2 Clinical Trial beginning late 2016.  The trial will enroll approximately 357 patients across 7 investigative sites. This randomized, investigator-blinded, non-inferiority study will compare the safety and efficacy of DCL-101 to the current gold standard of colonoscopy preps, GoLYTELY®.  Additional data on tolerability and patient preferences will be collected.  

A subsidiary of the University of Western Ontario, Robarts is a global academic Clinical Research Organization (CRO) that provides a broad range of clinical research services to pharmaceutical and biotechnology companies, government agencies and academic investigators.

Dark Canyon Labs is especially excited to be working with Robarts because they are globally recognized for their innovation and specialized expertise in the processing and centralized review of GI endoscopic video recordings with Central Image Management Solutions (CIMS).

E.U. and Hong Kong Patents Pending

Dark Canyon Labs has patents pending in both the European Union as well as Hong Kong.  Long backlogs of applications have created delays.  Check back for updates.

Chinese Patent Granted to Dark Canyon Laboratories

Dark Canyon Labs was granted Chinese patent No. 201080028806.1  for development of a novel Colon Lavage System.

Japanese Patent Granted to Dark Canyon Laboratories

Dark Canyon Labs was granted Japanese Patent No. JP2012524788A for development of a novel Colon Lavage System.

Canadian Patent Granted to Dark Canyon Laboratories

Dark Canyon Labs was granted Canadian Patent No. CA 2759723 for development of a novel Colon Lavage System.

U.S. Patent Granted to Dark Canyon Laboratories

Dark Canyon Labs was granted U.S. Patent No. US 8,778,306 B2 for development of a novel Colon Lavage System.  

Australian Patent Granted to Dark Canyon Laboratories

Dark Canyon Labs was granted Australian Patent No. AU2010239378 for development of a novel Colon Lavage System.